313 related articles for article (PubMed ID: 29464004)
1. Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery.
Martinez JO; Molinaro R; Hartman KA; Boada C; Sukhovershin R; De Rosa E; Kirui D; Zhang S; Evangelopoulos M; Carter AM; Bibb JA; Cooke JP; Tasciotti E
Theranostics; 2018; 8(4):1131-1145. PubMed ID: 29464004
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma.
Molinaro R; Martinez JO; Zinger A; De Vita A; Storci G; Arrighetti N; De Rosa E; Hartman KA; Basu N; Taghipour N; Corbo C; Tasciotti E
Biomater Sci; 2020 Jan; 8(1):333-341. PubMed ID: 31714542
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Biomimetic, Leukocyte-Mimicking Nanovesicles for Drug Delivery Against Colorectal Cancer Using a Design of Experiment Approach.
Rampado R; Biccari A; D'Angelo E; Collino F; Cricrì G; Caliceti P; Giordano F; Taraballi F; Pucciarelli S; Agostini M
Front Bioeng Biotechnol; 2022; 10():883034. PubMed ID: 35757799
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
[TBL] [Abstract][Full Text] [Related]
5. Phototheranostics: Active Targeting of Orthotopic Glioma Using Biomimetic Proteolipid Nanoparticles.
Jia Y; Wang X; Hu D; Wang P; Liu Q; Zhang X; Jiang J; Liu X; Sheng Z; Liu B; Zheng H
ACS Nano; 2019 Jan; 13(1):386-398. PubMed ID: 30576599
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic proteolipid vesicles for targeting inflamed tissues.
Molinaro R; Corbo C; Martinez JO; Taraballi F; Evangelopoulos M; Minardi S; Yazdi IK; Zhao P; De Rosa E; Sherman MB; De Vita A; Toledano Furman NE; Wang X; Parodi A; Tasciotti E
Nat Mater; 2016 Sep; 15(9):1037-46. PubMed ID: 27213956
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic Shells Endow Sub-50 nm Nanoparticles with Ultrahigh Paclitaxel Payloads for Specific and Robust Chemotherapy.
Chen X; Ling X; Zhao L; Xiong F; Hollett G; Kang Y; Barrett A; Wu J
ACS Appl Mater Interfaces; 2018 Oct; 10(40):33976-33985. PubMed ID: 30203956
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin-mediated biomimetic synthesis of paramagnetic O
Shi X; Yang W; Ma Q; Lu Y; Xu Y; Bian K; Liu F; Shi C; Wang H; Shi Y; Zhang B
Theranostics; 2020; 10(25):11607-11621. PubMed ID: 33052236
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability.
Palomba R; Parodi A; Evangelopoulos M; Acciardo S; Corbo C; de Rosa E; Yazdi IK; Scaria S; Molinaro R; Furman NE; You J; Ferrari M; Salvatore F; Tasciotti E
Sci Rep; 2016 Oct; 6():34422. PubMed ID: 27703233
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.
Boada C; Zinger A; Tsao C; Zhao P; Martinez JO; Hartman K; Naoi T; Sukhoveshin R; Sushnitha M; Molinaro R; Trachtenberg B; Cooke JP; Tasciotti E
Circ Res; 2020 Jan; 126(1):25-37. PubMed ID: 31647755
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-derived nanovesicles exert intrinsic anti-inflammatory properties and prolong survival in sepsis through a direct interaction with macrophages.
Molinaro R; Pastò A; Corbo C; Taraballi F; Giordano F; Martinez JO; Zhao P; Wang X; Zinger A; Boada C; Hartman KA; Tasciotti E
Nanoscale; 2019 Jul; 11(28):13576-13586. PubMed ID: 31290914
[TBL] [Abstract][Full Text] [Related]
12. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites.
Napp J; Markus MA; Heck JG; Dullin C; Möbius W; Gorpas D; Feldmann C; Alves F
Theranostics; 2018; 8(22):6367-6383. PubMed ID: 30613305
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Specific Endogenous Fe
Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740
[TBL] [Abstract][Full Text] [Related]
15. Potential of mZD7349-conjugated PLGA nanoparticles for selective targeting of vascular cell-adhesion molecule-1 in inflamed endothelium.
Imanparast F; Paknejad M; Faramarzi MA; Kobarfard F; Amani A; Doosti M
Microvasc Res; 2016 Jul; 106():110-6. PubMed ID: 27105996
[TBL] [Abstract][Full Text] [Related]
16. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
Zhu D; Lu X; Hardy PA; Leggas M; Jay M
Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic Nanoparticles as a Theranostic Tool for Traumatic Brain Injury.
Zinger A; Soriano S; Baudo G; De Rosa E; Taraballi F; Villapol S
Adv Funct Mater; 2021 Jul; 31(30):2100722. PubMed ID: 34413716
[TBL] [Abstract][Full Text] [Related]
18.
Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
[No Abstract] [Full Text] [Related]
19. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.
Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
Jiao Y; Sun Y; Tang X; Ren Q; Yang W
Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
